Sector Cardiol Therapeutics Inc.

Aandelen

CRDL

CA14161Y2006

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 22:00:00 16-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
1,580 CAD -1,25% Intraday-grafiek van Cardiol Therapeutics Inc. -14,59% +20,61%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-1,25%-14,59%-38,76%0,00%+20,61%+3,27%+43,64%-67,42% - 132 mln.
-6,60%-10,93%-7,90%+9,73%+59,20%+45,08%+60,01%-0,71% - 68,98 mld.
-4,09%+3,12%-15,28%-3,06%+1,51%+3,71%+53,50%+185,00%+4.786,50% 53,15 mld.
+0,03%+7,21%+12,43%+3,89%+12,31%+12,52%+44,46%-16,32%+231,87% 50,83 mld.
-1,53%+3,10%-1,03%+29,06%+18,41%+31,40%+33,88%+7,25%+254,26% 44,61 mld.
-5,97%-5,40%-13,13%-3,51%+123,43%+259,08%+494,98%+560,33% - 40,57 mld.
-1,34%+5,41%+6,51%+18,57%+21,48%+16,74%+106,42%+2,97%+1.070,88% 42,53 mld.
+6,53%+8,02%+9,30%+10,42%+12,54%+18,98%+54,58%+7,26%+169,34% 30,95 mld.
-0,90%-10,91%-2,07%+21,90%+53,31%+34,11%-1,83%-55,94% - 25,44 mld.
-2,76%-4,73%-9,29%-4,65%-7,87%-15,94%-15,32%-64,59% - 22,66 mld.
-1,07%+6,20%+16,37%+31,96%+23,43%+20,52%+10,51%-12,27%+122,80% 22,65 mld.
-2,96%-4,19%-19,72%-12,33%-44,69%-41,13%+288,81%+263,42%+600,66% 21,67 mld.
-1,61%+2,62%-0,32%+16,86%+10,12%+20,25%+158,67%+230,59%+2.018,05% 17,55 mld.
+3,32%+4,18%+3,32%-5,68%+193,84%+168,17%+386,54%+1.614,31%+817,72% 15,42 mld.
-0,95%+5,44%+9,37%+12,03%+41,98%+55,46%+191,34%+185,20%+449,73% 15,57 mld.
-1,14%+3,38%+6,51%+12,93%+25,42%+26,55%+57,62%-27,90%+87,27% 15,4 mld.
-0,60%+1,15%-6,06%-16,13% - - - - - 14,88 mld.
-1,99%+0,72%+9,99%+31,52%+50,47%+75,81%+57,13%-25,62%+272,63% 14,62 mld.
+3,10%+1,39%-2,25%-15,75%+15,25%-3,54%+445,89% - - 13,35 mld.
-2,83%+3,45%-1,32%-1,10%-6,61%-9,41%-31,17%-38,13%+120,84% 13,51 mld.
Gemiddelde -1,23%+1,69%-2,17%+6,83%+32,85%+37,98%+128,40%+152,64%+846,35% 27,22 mld.
Gewogen gemiddelde per kap. -1,94%+2,18%-1,40%+8,21%+33,47%+42,28%+117,33%+126,68%+1.132,90%
  1. Beurs
  2. Aandelen
  3. Koers CRDL
  4. Sector Cardiol Therapeutics Inc.